Fort, L.P. Ionis Pharmaceuticals Inc Transaction History

Fort, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$42.51 - $63.78 $163,535 - $245,361	-3,847 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$45.3 - $60.27 $44,394 - $59,064	-980 Reduced 20.3%	3,847 $218,000
Q3 2020 Nov 13, 2020	BUY	$47.45 - $62.95 $229,041 - $303,859	4,827 New	4,827 $229,000

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Fort, L.P., based on Form 13F filings with the SEC.

Stay updated on Fort, L.P. with notifications on news.